Literature DB >> 16522786

Role of macrophage migration inhibitory factor in hepatitis B virus-specific cytotoxic-T-lymphocyte-induced liver injury.

Kiminori Kimura1, Masahito Nagaki, Jun Nishihira, Shinichi Satake, Kazuo Kuwata, Hisataka Moriwaki.   

Abstract

Macrophage migration inhibitory factor (MIF) plays a pivotal role in the development of various inflammatory diseases. Here, we found that anti-mouse MIF antibody treatment reduced liver injury and inflammatory cell infiltration into the liver after injection of antigen-specific cytotoxic T lymphocytes into hepatitis B virus transgenic mice.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16522786      PMCID： PMC1391960          DOI： 10.1128/CVI.13.3.415-419.2006

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  24 in total

1.  Protection from septic shock by neutralization of macrophage migration inhibitory factor.

Authors:  T Calandra; B Echtenacher; D L Roy; J Pugin; C N Metz; L Hültner; D Heumann; D Männel; R Bucala; M P Glauser
Journal:  Nat Med       Date:  2000-02       Impact factor: 53.440

2.  Development of chronic colitis is dependent on the cytokine MIF.

Authors:  Y P de Jong; A C Abadia-Molina; A R Satoskar; K Clarke; S T Rietdijk; W A Faubion; E Mizoguchi; C N Metz; M Alsahli; T ten Hove; A C Keates; J B Lubetsky; R J Farrell; P Michetti; S J van Deventer; E Lolis; J R David; A K Bhan; C Terhorst; M A Sahli
Journal:  Nat Immunol       Date:  2001-11       Impact factor: 25.606

3.  Blockade of neutrophil elastase attenuates severe liver injury in hepatitis B transgenic mice.

Authors:  Shinji Takai; Kiminori Kimura; Masahito Nagaki; Shinichi Satake; Kazuhiro Kakimi; Hisataka Moriwaki
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

Review 4.  Noncytolytic control of viral infections by the innate and adaptive immune response.

Authors:  L G Guidotti; F V Chisari
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

5.  Cytokine-sensitive replication of hepatitis B virus in immortalized mouse hepatocyte cultures.

Authors:  Valérie Pasquetto; Stefan F Wieland; Susan L Uprichard; Marco Tripodi; Francis V Chisari
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

6.  Ubiquitous production of macrophage migration inhibitory factor by human gastric and intestinal epithelium.

Authors:  Christian Maaser; Lars Eckmann; Günther Paesold; Hyun S Kim; Martin F Kagnoff
Journal:  Gastroenterology       Date:  2002-03       Impact factor: 22.682

7.  Macrophage migration inhibitory factor is a critical mediator of severe acute pancreatitis.

Authors:  Yoshitaka Sakai; Atsushi Masamune; Akihiko Satoh; Jun Nishihira; Tetsuya Yamagiwa; Tooru Shimosegawa
Journal:  Gastroenterology       Date:  2003-03       Impact factor: 22.682

8.  Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice.

Authors:  Kiminori Kimura; Kazuhiro Kakimi; Stefan Wieland; Luca G Guidotti; Francis V Chisari
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

9.  Activated intrahepatic antigen-presenting cells inhibit hepatitis B virus replication in the liver of transgenic mice.

Authors:  Kiminori Kimura; Kazuhiro Kakimi; Stefan Wieland; Luca G Guidotti; Francis V Chisari
Journal:  J Immunol       Date:  2002-11-01       Impact factor: 5.422

Review 10.  Macrophage migration inhibitory factor: a regulator of innate immunity.

Authors:  Thierry Calandra; Thierry Roger
Journal:  Nat Rev Immunol       Date:  2003-10       Impact factor: 53.106
View more
  4 in total

Review 1.  Cytokinome profile evaluation in patients with hepatitis C virus infection.

Authors:  Francesca Capone; Eliana Guerriero; Giovanni Colonna; Patrizia Maio; Alessandra Mangia; Giuseppe Castello; Susan Costantini
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

2.  Role of CD44 in CTL-induced acute liver injury in hepatitis B virus transgenic mice.

Authors:  Kiminori Kimura; Masahito Nagaki; Masanao Saio; Hisataka Moriwaki; Kazuhiro Kakimi
Journal:  J Gastroenterol       Date:  2009-02-13       Impact factor: 7.527

3.  Abrogation of macrophage migration inhibitory factor decreases West Nile virus lethality by limiting viral neuroinvasion.

Authors:  Alvaro Arjona; Harald G Foellmer; Terrence Town; Lin Leng; Courtney McDonald; Tian Wang; Susan J Wong; Ruth R Montgomery; Erol Fikrig; Richard Bucala
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

4.  Elevated serum levels of macrophage migration inhibitory factor are associated with progressive chronic cardiomyopathy in patients with Chagas disease.

Authors:  Romina A Cutrullis; Patricia B Petray; Edgardo Schapachnik; Rubén Sánchez; Miriam Postan; Mariela N González; Valentina Martín; Ricardo S Corral
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.